MTOR and hepatocellular carcinoma: Hence, Lou et al. observed the adriamycin sensitivity of HCC was reinforced by mir‐199a modified adipose tissue‐derived mesenchymal stem cell exosomes (ADMSC‐Exo‐199a) through the mTOR pathway.34